Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Prostate Cancer Metastatic × Dexamethasone × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Multiple Myeloma 665 Precursor Cell Lymphoblastic Leukemia-Lymphoma 143 Recurrence 106 Neoplasms, Plasma Cell 97 Leukemia 78 Lymphoma 74 Neoplasms 70 Vomiting 47 Burkitt Lymphoma 44 Lymphoma, Non-Hodgkin 41 Immunoglobulin Light-chain Amyloidosis 40 Lymphoma, Large B-Cell, Diffuse 33 Lymphoma, Mantle-Cell 31 Nausea 30 Prostatic Neoplasms 29 Lymphoma, Follicular 27 Waldenstrom Macroglobulinemia 26 Neoplasm Metastasis 23 Breast Neoplasms 23 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 22 Leukemia, Myeloid, Acute 22 Hodgkin Disease 22 Leukemia, Lymphocytic, Chronic, B-Cell 21 Carcinoma, Non-Small-Cell Lung 21 Lung Neoplasms 19 Amyloidosis 16 Lymphoma, Extranodal NK-T-Cell 14 Lymphoma, B-Cell, Marginal Zone 14 Leukemia, Biphenotypic, Acute 14 Colorectal Neoplasms 13

Interventions

enzalutamide 7 Prednisone 7 cabazitaxel 6 Radiosurgery 5 Docetaxel 5 Androgen Antagonists 4 Abiraterone Acetate 4 XRP6258 2 talazoparib 1 sipuleucel-T 1 rucaparib 1 pembrolizumab 1 olaparib 1 gallium 68 PSMA-11 1 fludrocortisone acetate 1 darolutamide 1 apalutamide 1 Zuclomiphene 1 Standard of Care 1 Radiotherapy, Image-Guided 1 Radiotherapy 1 Prednisolone 1 Positron Emission Tomography Computed Tomography 1 Pluvicto 1 Lutetium-177 1 Lutetium 1 Lenograstim 1 LY3023414 1 Injections 1 Hydrocortisone 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06136624 2026-03-11

OMAHA-003

Merck Sharp & Dohme LLC

Phase 3 Recruiting

Prostate Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡